UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.980-988

2018

Volltextzugriff (PDF)

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1162-1169

2018

Volltextzugriff (PDF)

Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe

Journal of viral hepatitis, 2018-03, Vol.25 (S1), p.6-17

2018

Volltextzugriff (PDF)

Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.139-149

2017

Volltextzugriff (PDF)

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (4), p.451-459

2018

Volltextzugriff (PDF)

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (1), p.86-94

2018

Volltextzugriff (PDF)

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.966-979

2018

Volltextzugriff (PDF)

Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis

Journal of gastroenterology, 2012-05, Vol.47 (5), p.561-568

2012

Volltextzugriff (PDF)

Editorial: dynamic changes of the inflammation‐based index predict mortality following chemoembolisation for hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2015-06, Vol.41 (11), p.1216-1217

Peck‐Radosavljevic, M.

2015

Volltextzugriff (PDF)

Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2014-02, Vol.39 (3), p.331-338

2014

Volltextzugriff (PDF)

Letter: sustained virological response and liver healing – authors' reply

Alimentary pharmacology & therapeutics, 2017-04, Vol.45 (8), p.1173-1174

2017

Volltextzugriff (PDF)

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (1), p.83-91

2012

Volltextzugriff (PDF)

Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients

Journal of viral hepatitis, 2012-11, Vol.19 (11), p.801-810

2012

Volltextzugriff (PDF)

Review article: coagulation disorders in chronic liver disease

Alimentary pharmacology & therapeutics, 2007-11, Vol.26 (s1), p.21-28

PECK‐RADOSAVLJEVIC, M.

2007

Volltextzugriff (PDF)

Interferon‐free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses

Alimentary pharmacology & therapeutics, 2015-09, Vol.42 (6), p.707-718

2015

Volltextzugriff (PDF)

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (8), p.949-959

2011

Volltextzugriff (PDF)

Letter: can persisting liver stiffness indicate increased risk for HCC, after successful anti‐HCV therapy? – authors’ reply

Alimentary pharmacology & therapeutics, 2016-02, Vol.43 (4), p.544-545

2016

Volltextzugriff (PDF)

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

Cancer imaging, 2022-01, Vol.22 (1), p.1-1, Article 1

2022

Volltextzugriff (PDF)

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

Journal of viral hepatitis, 2010-06, Vol.17 (6), p.400-409

2010

Volltextzugriff (PDF)

Diagnostic workup of primary sclerosing cholangitis: The benefit of adding gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography to conventional T2-weighted magnetic resonance cholangiography

Clinical radiology, 2014-05, Vol.69 (5), p.499-508

2014

Volltextzugriff (PDF)

Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patients

Journal of viral hepatitis, 2014-07, Vol.21 (7), p.508-516

2014

Volltextzugriff (PDF)

Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

Annals of oncology, 2016-05, Vol.27 (5), p.856-861

2016

Volltextzugriff (PDF)

Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels

Journal of viral hepatitis, 2014-01, Vol.21 (1), p.33-41

2014

Volltextzugriff (PDF)

240 MEASUREMENT OF LIVER STIFFNESS IN CHRONIC LIVER DISEASES VIA SHEAR WAVE ELASTOGRAPHY (AIXPLORER®): A VALID SUBSTITUTION FOR TRANSIENT ELASTOGRAPHY (FIBROSCAN®)?

Journal of hepatology, 2013-04, Vol.58, p.S103-S103

2013

Volltextzugriff (PDF)

Prophylactic Bisphosphonate Treatment Prevents Bone Fractures After Liver Transplantation

American journal of transplantation, 2007-07, Vol.7 (7), p.1763-1769

2007

Volltextzugriff (PDF)

1 – 25 von 435

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(431)
Mit Volltextzugriff
(332)

Publikationsform

Sprache

Englisch
(394)
Deutsch
(86)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Gastroenterology And Hepatology
(126)
Science & Technology
(122)
Life Sciences & Biomedicine
(121)
Humans
(116)
Male
(89)
Female
(83)
Middle Aged
(78)
Gastroenterology & Hepatology
(67)
Adult
(66)
Biological And Medical Sciences
(47)
Medical Sciences
(47)
Aged
(46)
Treatment Outcome
(28)
Infectious Diseases
(23)
Gastroenterology. Liver. Pancreas. Abdomen
(22)
Pharmacology & Pharmacy
(21)
Cirrhosis
(20)
Hepatitis C, Chronic - Drug Therapy
(20)
Retrospective Studies
(20)
Liver Transplantation
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose‐response study

Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe

Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding

Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis

Editorial: dynamic changes of the inflammation‐based index predict mortality following chemoembolisation for hepatocellular carcinoma

Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

Letter: sustained virological response and liver healing – authors' reply

The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study

Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients

Review article: coagulation disorders in chronic liver disease

Interferon‐free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responses

Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib

Letter: can persisting liver stiffness indicate increased risk for HCC, after successful anti‐HCV therapy? – authors’ reply

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

Diagnostic workup of primary sclerosing cholangitis: The benefit of adding gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography to conventional T2-weighted magnetic resonance cholangiography

Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patients

Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels

240 MEASUREMENT OF LIVER STIFFNESS IN CHRONIC LIVER DISEASES VIA SHEAR WAVE ELASTOGRAPHY (AIXPLORER®): A VALID SUBSTITUTION FOR TRANSIENT ELASTOGRAPHY (FIBROSCAN®)?

Prophylactic Bisphosphonate Treatment Prevents Bone Fractures After Liver Transplantation

Suchergebnisse filtern